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ABSTRACT
This study was an investigation into the cost-effectiveness of usmg re-usable
instrumentation in laparoscopic surgery. The model used for the study was the
laparoscopic cholecystectomy which is the commonest laparoscopic procedure performed
by the general surgeons. The study was done at KZNGOV Hospital in Kwazulu Natal,
one of the largest tertiary hospitals in the province. The research done was both
qualitative and quantitative. An exploratory study was conducted initially by drawing up
the case study, and then quantitative and qualitative research was conducted to evaluate
the use of re-usable instrumentation in laparoscopic surgery. In order to conduct a more
focused design, the three most commonly used laparoscopic instruments were evaluated.
These were the trocars (sizes II.Omm and 5.0mm), the endoshears / scissors and the clip
applicators. The study aimed to assess whether the use of the re-usable instruments was
more cost-effective, whether their use in minimal access surgery was feasible, and
whether the use of re-usable instrumentation compromised patient well-being.
Information for the case study was obtained from the hospital notes of the patients who
had a laparoscopic cholecystectomy at KZNGOV Hospital, and from interviews with
experienced surgeons.
The study found that the re-usable instrumentation used at KZNGOV Hospital had no
adverse effects on the patients. The Department of Surgery and the theatre committee at
this hospital have chosen an excellent and cost-effective protocol for laparoscopic
surgery, and the choice of instrumentation cannot be faulted. Analysis of the results
showed a large cost saving obtained by using the re-usable laparoscopic instrumentation,
with no adverse patient outcomes.
y
... (W)e have not had any formal instruction in the morality of
spending other people's money or in the practical
details ofthe economics that underpin the health care
field. Like our patients, we have not had any
incentive to change.
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CHAPTER ONE: INTRODUCTION TO THE RESEARCH
1.1. Introduction
The term Minimally Invasive Surgery describes those diagnostic or therapeutic
procedures that can be performed using smaller, and in some cases, no incisions in the
abdomen and chest. George Kelling was the first physician to examine the abdominal
cavity with an endoscope in 1901. Patients and physicians alike, have rapidly embraced
these procedures because they are perceived to be associated with less post-operative
pain, shorter recovery periods, and fewer complications than traditional open surgery.





The model used for this research project is the Laparoscopic Cholecystectomy, and
specifically the instrumentation that is used in these procedures. This model was chosen
because it continues to be the most common therapeutic rigid endoscopic procedure
performed by general surgeons (Zucker and Curet, 1995).
1.2. Background into the Research
Within our present economic situation in South Africa, inflation has been steadily rising.
This also impacts on medical costs to the patient and the health insurance companies.
Medical aid companies and patients are finding it difficult to cope with the increasing
costs of drugs, doctors' fees and hospitalisation costs. Health insurance premiums are
increasing constantly. In many instances the patient has to bear a large part of the costs
of medical and hospital fees himlherself, as medical aid companies do not always cover
the full costs ofmedical bills.
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The laparoscopic cholecystectomy is performed both in the private hospitals, and in the
public-sector or government-funded hospitals. The instrumentation used during the
cholecystectomy in these two sectors is slightly different. The private sector uses
disposable instruments, which are pre-packed by the pharmaceutical companies, whereas
in the public-sector, due to budgetary constraints, non-disposable instruments are used.
These are re-sterilised after each procedure.
In medical practice, costs and quality are inextricably intertwined (Traverso 1996). The
quality of our health care service has to assessed, increased, and then maintained before
cost is considered. Because oftechnological advancements, many surgeons are now able
to incorporate minimally invasive techniques into everyday practice. Unfortunately the
costs for these procedures, and specifically the instrumentation they use, is steadily
increasing.
The problem at the forefront of laparoscopic surgery today is the use of disposable
instrumentation, rather than the re-usable type. Disposable instruments cost far more
than their re-usable counterparts. This cost is eventually borne by the medical aid
companies and the patients. Pharmaceutical companies that manufacture these
instruments advocate the use of the disposable types. Their arguments are that
disposable instruments cause less injury to the patients and decrease the rate of post-
operative complications, especially infections.
The research problem for this study is whether using disposable instruments for
minimally invasive surgery is more cost effective than using the re-usable ones.
With the current economic situation in South Africa and the mY/AIDS pandemic, funds
for health care have to go further. The technology of laparoscopy has been explosive,
and has thereby increased health costs dramatically. Surgeons now have to contend with
a multifaceted force that drives health care. This force is confusing to surgeons because
many do not understand the business of medicine and business administrators do not
understand the science ofmedicine (Traverso 1996).
Traverso says that surgeons should first be interested in quality, and then dwell on a
reasonable cost for their health care product. The clinical perspective of quality is an
important concept to understand because quality must become part of any long-term
business decision.
The value of a procedure can be defined as a quality product provided at a reasonable
cost (Traverso 1996). The components of quality are appropriate utilisation of the
procedure with outcomes that fall within standardised short- and long-term results.
Traverso uses the following equation to equate these concepts:
Value = Appropriateness X Quality
Cost
1.3. Motivation for the Research
The current South African economic climate is forcing doctors to take a closer look at the
costs involved in delivering a quality health care product. The advent of laparoscopic
cholecystectomy has been of great economic benefit both to surgeons and patients. This
is in part due to a reduced length ofhospital stay, reduced post-operative morbidity and a
quicker resumption to normal activities of the patient. However, the cost oflaparoscopic
procedures is increasing due to more "technologically advanced" instrumentation.
Pharmaceutical companies have had an enormous impact on minimal access surgery
(MAS). The use of the instrumentation and equipment has not adequately been judged
or challenged up to now. This research aims to challenge the standard practice of
minimal access surgery with respect to the instrumentation used. If non-disposable
equipment is shown to be equally efficacious (as compared to the disposable
instruments), this has far-reaching implications with regard to cost savings to the health
industry, medical aid schemes and to the patient in particular.
Disposable equipment for minimal access surgery is not widely available in the public
sector or government-funded hospitals. This research also aims to reveal if patients
treated in government hospitals are compromised in any way by these hospitals not
having access to disposable instrumentation for MAS.
This research aims to find an objective viewpoint with respect to the use of this
instrumentation and equipment, which is a costly component of minimal access surgical
procedures.
1.4. Value of the Research
The costs of health care in South Africa and throughout the world have gone up
considerably. The laparoscopic procedures and laparoscopic technology has increased
dramatically over the last few decades. This has brought with it increasing equipment
costs. More and more newer and more advanced instruments are coming onto the
market almost every day. The number of laparoscopies being done now is also
increasing. There is especially an increase in laparoscopic cholecystectomies. This is
due to two factors:
• There is now an increased patient demand for these procedures.
• Relaxation of criteria by gastro-enterologists for referral of patients with gallstones
for surgery is also a contributing factor.
A study done by Orlando and Russel in Connecticut in 1996 showed a 29% increase in
the overall rate of laparoscopic cholecystectomies.
South Africa is both a first world and a third world country rolled into one. This has
impacted on health care in this country. The public and private sectors are vastly
different from each other, yet they influence each other greatly, especially from a
fmancial viewpoint. Private patients who run out of medical aid cover eventually
become a burden to the state. Thus medical aid funds should be used with care. If
private charges decrease because of careful use of funds for medication, instrumentation
and hospitalisation, the medical aid premiums will subsequently decrease. This would
be of enormous benefit to the patient. More people may be able to afford health
insurance and this would reduce the load on the already over-burdened public sector.
Many patients without medical insurance also seek private care in order to avoid the long
waiting times in the government hospitals. If medical costs can be brought down, these
patients would also benefit. Many ofthese patients are not wealthy and can ill afford the
high cost of medical care. Government is also one of the largest employers in the
country and subsidise their employees' medical aid schemes heavily. If health insurance
premiums continue to rise due to the escalating costs of medical care, government may
not be able to sustain these subsidies indefinitely (Comell, McIntyre and Mbatsha, 2001).
1.5. Problem statement
Does the use of re-usable instrumentation in laparoscopic cholecystectomies decrease
overall costs for the operation, and do they compromise patient well-being in any way?
1.6. Research Questions
This research aims to answer three specific questions:
1. Is the use ofthe instrumentation used in minimal access surgery cost-effective? The
equipment currently used in MAS is either disposable or re-usable. This research aims
to specifically evaluate the implications of using re-usable equipment. With regard to
the cost-effectiveness of MAS, we are looking at this from purely an instrumentation
point of view. Surgeon's fees, theatre fees and hospitalisation costs will not be
investigated.
2. Is the use of re-usable instrumentation in MAS feasible? Does the use of re-usable
equipment compromise surgical technique, or patient well-being?
3. What is the outcome ofusing re-usable equipment? Here we will look specifically at
patient outcome. The outcome evaluated will include:
• The intra-operative procedure - do instruments (disposable or re-usable) impact on
surgical technique?
• Are there any complications that develop consequent to usmg the re-usable
instruments?
• Is the hospital stay of the patient, patient recovery time, and return of the patient to
normal activity in any way affected?
By answering the above questions, this dissertation hopes to add new knowledge to the
field of study of the cost implications of the use of specific instrumentation in minimal
access surgical procedures. This research also hopes to stimulate further study into this
relatively new area of surgery, which is increasing at a phenomenal rate in both the
private and public health sectors.
1.7. Objectives of the Study
The following are the objectives of the study:
• To evaluate the different types of laparoscopic equipment on offer at present, and to
ascertain their impact on health care costs.
• To determine whether medical care available in South Africa is based on sound
principles ofcost-effectiveness.
• To establish the most cost effective way to deliver quality health care to the South
African population. Quality of health care should be uppermost in the surgeon's
mind, and costs should take second place. The model of the laparoscopic
cholecystectomy is used in this study, because it is one of the most common
laparoscopic procedures in general surgery. It must also be remembered that many
other laparoscopic procedures are being performed in general surgery and in other
medical specialities. Thus the findings of this study may be extrapolated to many
other disciplines in medicine.
1.8. Research Methodology
This is the description of the research methodology used to conduct the research for this
case study on KZNGOV Hospital in Kwazulu Natal. The research question is:
Does the use of re-usable instrumentation in laparoscopic cholecystectomies affect the
patient in any adverse way?
After identifying the research problem, the conclusion derived from the literature review
was based on the following constructs:
• Cost-effectiveness
• Feasibility of the use ofre-usable instruments
• Patient outcome.
1.8.1. Research Method
Both quantitative and qualitative research was carried out for this study. The qualitative
study was done in order to ascertain what the senior surgeons from the Department of
Surgery at KZNGOV Hospital thought about the use of re-usable instruments in
laparoscopic cholecystectomies. Thereafter a quantitative study was done to verify the
results from the qualitative study. This type of research design is known as the
triangulation method. This research methodology involves the use of both qualitative
and quantitative research approaches.
1.8.2. Sample
The sampling method used was non-probability sampling, obtaining a convenience
sample. Two sets of samples were used:
• All patients who had undergone a laparoscopic cholecystectomy from the beginning
of January 2002 to the end of January 2003. The fifty patients chosen from these
were the ones who had complete in-patient and out-patient notes.
• All senior surgical registrars and consultants from the Department of Surgery at
KZNGOV Hospital.
1.8.3. Qualitative Design
The research study attempts to evaluate whether the use of re-usable instrumentation in
laparoscopic cholecystectomies is cost-effective, affects surgical technique and adversely
affects patient well-being. An exploratory study using the case-study method was used.
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1.8.4. Sources of Evidence
• Interviews
Semi-stuctured interviews were conducted with three of the senior surgical registrars and
the surgical consultants from the six surgical units of the Department of Surgery at
KZNGOV Hospital. The rest of the consultants and registrars were either unavailable or
had emigrated. Some questions were open-ended, whereas others required shorter and
more precise answers. These questions attempted to bring out respondents' opinions
about the three constructs that were described earlier. The interview questions set-up
followed a focused interview style. The respondents were interviewed for a short period
oftime. Although interviews were open-ended and took on a conversational manner, the
interviewer followed a set ofquestions.
1.8.5. Measuring Instrument
• Interviews
The interview questions dealt with the three constructs described before. These are:
a. Cost-effectiveness
b. Feasibility ofusing re-usable instruments
c. Patient outcome.
The main stakeholders interviewed were the senior surgical registrars and the surgical
consultants from the Department of Surgery. All these surgeons have their surgical
degrees and are comparable to the surgeons that work in the private sector. The
questions were specific and were appropriate to all the interviewees.
Construct One: Cost-effectiveness
The questions posed had to indicate whether these experienced surgeons thought that
disposable instruments were in any way more cost-effective or superior to their re-usable
couterparts.
Question 5: In your opinion are disposable instruments used ID laparoscopic
cholecycstectomies more cost effective?
Question 6: Do you consider disposable instrumentation superior in quality to the re-
usable devices?
Question 7: Which of the two types of instruments - disposable or re-usable - do you
prefer to use? Why?
Construct Two: Feasibility
The following questions focused on the practicality and convenience of using re-usable
laparoscopic instrumentation.
Question 8: Is it more difficult to perform a laparoscopic cholecystectomy using re-usable
devices?
Question 9: Do re-usable instruments hamper the operative technique of laparoscopic
cholecystectomies in any way?
Construct Three: Patient outcome
For this construct the most common complications that anse from performing
laparoscopic procedures were considered. Manufacturers of disposable laparoscopic
devices say that these arise more commonly with the use ofre-usable instruments.
Question 10: Have you had any of the following adverse patient outcomes by using re-
usable instruments during laparoscopic cholecystectomies?
• Bowel/other organ injury?
• Increased rate of intra-abdominal infection?
• Excessive intra-abdominal bleeding immediately post-operatively?
• Delayed intra-abdominal bleeding post-operatively?
• Increased rate ofwound sepsis?
1.8.6. Quantitative Design
Quantitative research describes, explains and tests relationships. Techniques that are
used generate numerical data. Evaluation of the cost-effectiveness in using the different
types of laparoscopic instrumentation is very important to KZNGOV Hospita~ and to the
health care sector as a whole. As can be seen from previous discussions, the public and
private sectors do not work in isolation. For the evaluation process the complete hospital
records of fifty patients that underwent laparoscopic cholecystectomies were scrutinised.




• Length ofhospital stay.
• Duration ofoperation
• Organ injury at operation
• Bleeding during the operation
• Immediate bleeding after the operation
• Infection two weeks post-operatively
• Difficulty with surgical technique
• Additional medical conditions ofpatient
1.8.7. Patient Sample
The patient sample chosen was a convenience sample. All patients who had had a
laparoscopic cholecystectomy at KZNGOV Hospital between the periods I January 2002
to 31 January 2003 were chosen. A minimum number of 50 patients were needed for
this study. Only patients with both complete in-patient and out-patient notes were
selected for the study. This had to be done in order to evaluate both the immediate and
the 6-week post-operative time periods. The following table summarises the numbers of
patients who had had laparoscopic cholecystectomies during this time frame:
Table 1.1: Patients that Underwent Lap Choles from 11112002 to 311112003
Total number ofLap Choles from 1/1/2002 to 21/1/2003 95
No. ofpatients with complete in-patient notes only 13
No. ofpatients with complete out-patient notes only 14
No. ofpatients with both in-patient and out-patient notes (complete) 50
No. ofpatients whose in-patient and outpatients files were missing 18
The difficulty of obtaining both complete in-patient and out-patient files of all the
laparoscopic cholecystectomy patients from 1/1/2002 to 31/1/2003 was due to two
factors:
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• There was a computer crash at the hospital in November 2002, thus the notes were
not fIled according to their computer numbers, and
• There was wilful damage to the outpatient filing area in December 2002.
1.9. Limitations of the Study
• The major limitation of this study was to get sales representatives from disposable
instrument manufacturers to divulge any information about the costs of their
instruments.
• Another limitation was to obtain interviews with general surgeons in private practice
i.e. surgeons who utilise disposable instruments most of the time. Only one private
surgeon was agreeable to the interview. The rest politely declined or were
unavailable.
• The third limitation to the study was that only three instruments were investigated.
Many disposable device manufacturers make up special sterile surgical packs of
disposable equipment for the private surgeons to utilise for their various procedures.
This will obviously increase the cost of the procedure quite dramatically. However,
the three instruments that were the focus of this study are common to most
laparoscopic procedures, and are the most costly.
1.10. Summary
The debate over whether to use re-usable instruments or the disposable types in
laparoscopic surgery has been an ongoing and controversial one. Disposable device
manufacturers have maintained that their products are safer, easier to use, cause less
infections and cause fewer injuries to the patients. These are the arguments that these
manufacturers use to justify the high costs of the disposable instrumentation. The next
chapter investigates the theories behind these claims and looks at various studies done
throughout the world.
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CHAPTER TWO: LITERATURE REVIEW
2.1. Introduction
The literature review section is centred around the research questions stated in the
previous chapter. These factors are:
• Cost-effectiveness ofthe instrumentation used in Minimal Access Surgery.
• Feasibility ofthe use ofre-usable instruments in Minimal Access Surgery.
• Patient outcome when re-usable instrumentation is employed in Minimal Access
Surgery.
Before these questions are examined in greater detail, the South African health budget,
health legislation and the different health sectors will be looked at. The health sectors
concerned include the public and the private sectors. This is an important part of this
report as it gives one a background to the way health care is funded and regulated in
South Africa. Cost-effectiveness in the health care sector cannot be viewed in isolation.
2.2. The 200312004 Health Budget
The aim of the Department of Health is to promote the health of all people in South
Africa through a caring and effective national health system based on the primary health
care approach. This aim is to be achieved through three programmes.
• Programme l: Administration
The purpose of this programme is to provide for the overall management of the
department and provide legislative and communication services and centralised
administrative support.
• Programme 2: Strategic Health Programmes
These programmes co-ordinate a range of strategic national health programmes through
the development of policy, systems and monitoring, and manage and fund key
programmes. One of the objectives of Programme 2 is to support the development of
affordable health services and coherent service provision and financing in the private
health sector.
• Programme 3: Health Service Delivery
This programme supports the delivery of services primarily in the provincial and local
spheres ofGovernment.
. 2.2.1. Strategic Overview and Key Policy Developments of the Department of
Health: 199912000 - 2005/2006
Key functions of the national Department of Health are to lead and co-ordinate the
national health system'through the development ofpolicy, legislation and national health
programmes, and to support and monitor the implementation of policy by provincial and
local governments. A small core budget of about R582 million for 2003/2004 funds this
co-ordinating and support role in relation to a range of departmental transfers to public
entities and provinces as well as broader health spending funded from provincial
equitable share allocations. The total public sector health budget, including provincial
and national public health spending, will exceed R43 billion in 2005/2006.
Ongoing programmes are in place to improve the quality of hospital services. These
span the areas of infrastructure improvement, management improvement, norms and
standards for service delivery, and the increased use of public-private partnerships in the
operation of hospitals. The Inkosi Albert Luthuli Hospital in Durban is an example of a
large health infrastructure project that is being managed through a public-private
partnership. Other significant public-private partnerships are under investigation in the
Free State and will be boosted by the drive for differential amenities in public hospitals to
use capacity more effectively by providing services to private medical scheme patients.
The financial year of 200112002 was characterised by sharp increases in the prices of
medical consumables and equipment as the Rand depreciated. This threatened service
delivery levels in provincial health departments.
2.2.2. Council for Medical Schemes
The Council for Medical Schemes regulates the private medical schemes industry in
terms ofthe Medical Schemes Act (131 of 1998), and is funded mainly through levies on
the industry in terms of the Council for Medical Schemes Levies Act (58 of 2000). In
addition it receives a small transfer from the Department of Health, increasing from R2.6
million in 2002/2003 to R3.0 million in 2005/2006. The Council for Medical Schemes is
a public entity that reports to the Minister ofHealth.
2.3. Health Legislation in South Africa
Health legislation is recognised the world over as being both complex and fraught with
stakeholder interests (South African Health Review 2001). The World Health
Organisation states "the careful and responsible management of the well-being of the
population is the very essence of good government". In the South African context this
means the establishment of the best and fairest health system possible with available
resources.
The private healthcare sector consumes well over halfof all healthcare resources in South
Africa (South African Health Review 1998). In 1995 medical schemes spent more than
four times as much as the state per head ofcovered population.
2.3.1. The Regulation of Private Health Care Financing in South Africa
The medical schemes have been regulated by the Medical Schemes Act of 1968. The
medical schemes industry underwent many de-regulations in the late 1980s and early
1990s. This resulted in the current level ofregulation ofhealth insurers to be minimal by
international standards. Thus there has been high levels of fraud and insolvency in this
sector, as well as insecurity for those patients who develop chronic illnesses or are elderly
(South African Health Review 1998).
The Committee of Enquiry into a National Health Insurance System for South Africa
recommended three broad areas ofnew regulation to be introduced. These are:
• Regulation enforcing risk-pooling between high and low risk enrolees.
• Regulation requiring that all cover include at least a minimum package of essential
hospital care.
• Regulation regarding oversight, financial reserves and guarantees, reporting
requirements, etc., to bolster the financial stability of the industry.
2.3.2. Medical Schemes Act of 1998
An important piece of legislation which was passed during 1998 was the Medical
Schemes Act of 1998 which repealed the Medical Schemes Act of 1967. It includes
measures that aim to achieve an appropriate demarcation between medical schemes and
insurance products. Thus it eliminates "cherry picking" of the healthiest clients by the
insurance industry.
The act prohibits risk-rating and exclusion from membership on the basis of age, gender
and state of health. Provision is also made for the introduction of a prescribed set of
minimum health care benefits that must be offered by medical schemes. A number of
requirements are proposed which are aimed at ensuring improved governance, financial
administration and accountability of schemes. In tenns of this Act the Council for
Medical Schemes will gain corporate status and be funded in part by levies on medical
schemes, while remaining ultimately accountable to the Minister ofHealth.
Cumulatively, the amendments will:
• Reform the financing ofprivate health care in South Africa.
• Improve equity ofaccess to private medical insurance.
• Lead to greater efficiency in the use ofresources in this sector.
This act was promulgated in the first week of January 1999 and finally published on 20
October 1999. It came into effect on 1st January 2000. The most significant component
of the regulations is a list of prescribed minimum benefit conditions. In respect of these
conditions, medical schemes are required to reimburse in full, without co-payment or the
use of deductibles, the diagnostic, treatment and care costs in at least one provider or
provider network, which must include the public hospital system. While medical
schemes may still employ techniques such as pre-authorisation, they are not entitled to
refuse authorisation ID a public hospital of standard treatment for any prescribed
minimum benefit.
Due to constant change in medical practice and available medical technology, the
Department of Health will review the list of prescribed minimum benefits every two
years, in consultation with the council for medical schemes, stakeholders, Provincial
Health Departments and consumer representatives. These reviews will provide
recommendations for revision of the regulations based on, amongst others, considerations
of:
• Cost-effectiveness
• Health policy developments
• The impact on medical scheme viability and its affordability to members.
The stated objectives of specifying a set ofprescribed minimum benefits are:
• To avoid incidents where individuals lose their medical scheme cover in the event of
serious illness and the consequent risk ofunfunded utilisation ofpublic hospitals
• To encourage improved efficiency in the allocation of private and public health care
resources.
The regulations hold potentially significant advantages for the public health sector which
has virtually attained a preferred provider status in terms of the regulations. If public
hospitals structure and market their services appropriately, they have the potential to
attract many more private patients and thereby attract a greater share of the revenue from
the private medical aid market.
2.4. Health Care Financing and Expenditure
This section looks at the National Health Accounts Project that was done in the 1990s.
2.4.1. Introduction
The National Health Accounts (NHA) Project was conducted in the late 1990s. The
NHA project was funded by the European Union. The NHA Project is the successor of
the Health Expenditure Review. The Review described patterns of health care financing
in apartheid South Africa, and highlighted extensive geographic disparities,
disproportionate spending on hospital-based care in the public sector, and severe cost
escalation in the private sector. The NHA Project evaluates the extent to which these
problems have been addressed by the reforms put in place by the new South African
Government during its first term in office. Doherty, Thomas, Muirhead and Mclntyre
have summarised the findings of the NHA Project in the South African Health Review
2002. Some oftheir findings follow.
The NHA Project reveals two eras ofpublic health sector financing:
• Era 1: From 1992/93 to 1997/98. During this time there was:
a. Substantial growth in government financing ofhealth care.
b. The redistribution ofhealth sector funds across provinces.
c. The shift ofresources to primary health care.
• Era 2: 1998/1999. This shows:
a. Falling per capita financing ofhealth care by government.
b. Reversal ofredistribution trends between provinces.
c. Limited growth in the primary health care sector.
The NHA Project also shows several key features of private health sector development
in the post-apartheid era. These include:
• Growth in private sector provision (this is most marked in the bed numbers).
• Rapid growth in expenditure.
• Decrease in the number ofpeople with regular access to private care.
These trends suggest an overall decline in value-for-money in the private sector prior to
the implementation in 2000 ofthe Medical Schemes Act of 1998.
2.4.2. Trends in the Overall Level of Finances Available for Health Care
In 1998/1999 South Africa devoted R70.2 billion to health care (SAHR 2000). This is
an unusually high proportion by international standards. This represented 8.8% of Gross
Domestic Product. The equivalent average figure for middle-income countries was
5.7%. There are also indications that South Africa is devoting increasing amounts to
health care. These findings are shown in the following graph.
Figure 2.1: Total and per capita financing of the health care sector using total
population figures, 1996/97-1998/99 (1999/00 prices)
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2.4.3. Trends in the Sources of Finance




• Donors and non-governmental organisations.
The changing relationships between these different sources show decreasing financial
support by government of health services for public sector dependants. This has
increased the burden on households and employers and funders of health care. The
following table shows the sources and the proportion of finances provided.
Table 2.1: Sources of Finance in the South African Health Care Sector, 1998/99
Sources of Finance 1999/00 prices 0/0 of total Change in %,
(Rand billion) sources 1997/98-
1998/99
Government 31.1 44.2 -4.8
Households 27.4 39.0 4.5
Employers 11.7 16.6 3.4
Donors and non-governmental 0.1 0.1 Unknown
organisations
Total 70.2 100.0
Source: South African Health Review 2002
2.4.4. Trends in Government Funding of Health Care
Government is the largest source of health care finance. The health sector is allocated a
portion ofgovernment finances which is raised from:
• Taxes - income tax, company tax, sales tax CVAT)
• Licences
• Sales ofutilities such as electricity and water.
94% of the amount of money raised by Government was contributed by central
government (1998/99 figures). Provincial and local government provided only 2.7% and
3.3% oftotal government health care finances from their own revenues respectively.
Signs that government financing was beginning to decrease started showing in 1997/98,
although government as a whole had increased its contributions to health care between
1992/93 and 1997/98. Government financing per person dependent on the public sector
increased by 4.3% between 1996/97 and 1997/98, but decreased by 2.5% between
1997/98 and 1998.99. Between 1996/97 and 1998/99 government finances declined
continually as a proportion of total health care finance, at an average annual rate of3.6%.
This trend is due to two factors:
1. A decline in GDP per capita (Department ofFinance 1999). This was largely due
to the global economic recession (South African Reserve Bank 2001).
11. Decreased government spending on health care was also a direct consequence of
the performance of the economy that faltered towards the end of the 1990s,
leading to this government policy. Between 1996/97 and 1998/99, government
health care financing declined as a proportion of GDP, of total government
fInancing, and oftotal government financing less debt servicing. Health care was
de-prioritised towards the end ofthe new government's first term of office. This
was due to the following factors:
• The government's macro-economic policy, the Growth, Employment and
Redistribution Strategy (GEAR) was initiated in 1996. The GEAR policy sets
limits on the tax to GDP ratio. This places a constraint on the finances available
to government, especially during an economic recession.
• The GEAR policy also insists that public expenditure growth be lower than
overall economic growth. This means that public expenditure is likely to
decrease in real per-capita terms (Thomas and Muirhead 2000).
• The social sector budgets are projected to increase between 1999/2000 and
2002/03 at a rate less than the increase in the overall government budget
(Department ofFinance 1999).
• Other sectors, including Defence, will grow at a faster rate.
Thus it is likely that the year-on-year growth in the health budget will average only 0.8%
for the period 2000/01 to 2002/03 (Thomas and Muirhead 2000). In terms of per capita
fIgures, this means a decline every year.
2.4.5. Trends in Household Funding of Health Care
The second largest source of finances for health care is households. Households either
pay contributions to medical schemes and other forms of private msurance, or pay
directly ("out-of-pocket") for services provided by health workers and facilities, and for
pharmaceuticals. Households contributed over a third of total health care finances in
1998/99. The increasing burden shouldered by households was mainly due to increased
out-of-pocket expenditure.
Figure 2.2: Sources of Finance for the Health Care sector, 1996/97 - 98/99
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Note: The contributions by donors are so small that they do not register on the graph.
Source: South African Health Review 2002.
2.4.6. Trends in Funding ofHealth Care by Employers
The third major source of finances is the employers. They also paid out more for the
health care of their employees over the period 1996/97 to 1998/99. The employers
include private firms as well as government-owned entities. They fund health care for
their employees either directly through health services provided at the workplace, or
indirectly through contributing to different forms of private insurance on behalf of their
employees. The proportion of fin~ces contributed by employers grew at a slightly
lower rate than that of households. This represented a fifth or less of total resources.
Most of the sources of finance were contributed by private employers. The growth was
due to increases in employers' contributions to employees' medical schemes. (This was
an annual average rate of approximatelyI I% in real terms). Employers also contributed
to the Workers' Compensation Fund at an annual rate ofapproximately 6%.
2.4.7. The Contributions of Donors and NGOs
Donors and non-governmental organisations are the fourth source of health care finance.
Unlike most countries in Africa, donor contributions represent only a very small
proportion of overall health care financing in South Africa. The source appears to be
growing as donors take an interest in the new government's policy to extend health care
services to the disadvantaged. But this does not alleviate the growing health care
fmancial burden shouldered by households in general.
2.5. The Flow of Finances Through Financing Intermediaries
Finances that are raised from a source flow through one or more financing intermediaries
before being passed on to a health care provider. The financing intermediaries who
control finances have a pronounced effect on efficiency and equity within the health
system, as they determine what resources are allocated to which populations, and for
which services. The following flow chart shows how finances for health care in South
Africa flow from financing sources to financing intermediaries.
Figure 2.3: The Flow of Financing Sources to Financing Intermediaries
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2.6. The Relative Size of Public and Private Financing Intermediaries
In South Africa the proportion of total finances controlled by privately owned
intermediaries increased from 56% to 59% between 1996/97 and 1998/99. This
represents an absolute increase of R8.8 billion in 1999/00 prices. Public sector
intermediaries grew at a much slower pace between 1996/97 and 1997/98, and actually
shrank between 1997/98 and 1998/99, as the following graph shows:
Figure2.4: The total Size of Public and Private Sector Financing Intermediaries,
















_Source: South African Health Review 2002
Despite the growing dominance of the private sector, it is estimated that less than 20% of
the total population made regular use of the full range of services in the private sector in
1998/99. The private sector coverage also decreased as a proportion of the total
population between 1996/97 and 1998/99 (Comell, McIntyre and Mbatsha, 2001). This
suggests that an increasing proportion ofthe population became reliant on public services
even as the public sector received a declining share ofhealth care finance. This reflected
the increasing un-affordability of scheme membership as costs escalated in the private
sector.
2.7. The Main Financing Intermediaries
Medical schemes are the main type of private insurance, the other much smaller type
being health insurance. Medical schemes are non-profit associations, but are operated by
professional administrators that are essentially for-profit companies. Schemes receive
monthly premiums from households and employers. Health insurance is offered by life
and short term insurance companies, and bought by households. Some of these
households also belong to medical schemes.





Other national departments (Defence, Education, Correctional Services, and
Safety and Security) 6.8
Regional gowrnment 82.0
Provincial Departments cl Hee~h 79.3
Provincial Departments of Works 2.7
Local government 5.6
Statu10ry Security SChemes 2.8
Workers' Compensation Fund 1.6
Road Accident Fund 1.2
Government direct expenditures anct compensation br health care for employees 0.1
PrivtltB sector
Private health Insul800e 68.3
Medical schemes 84.8
Hee~ insurance 3.5
Houll8holds' out-of-pocket payments made directly to public or private hee/lh serW:le8 30.1
Private firms' direct expenditure on wcrkplace health aervicea 1.6
Source: South African Health Review 2002
Table 2.2 breaks the public and private sectors into their component parts. The largest
intermediaries in 1998/99 were medical schemes (accounting for R2.9 billion in 1999/00
prices or 38% of total finances), and the provincial level government departments
(accounting for R23.5 billion in 1999/00 prices, or 34% of total finances). These two
groups were the dominant financing intermediaries in the South African health sector,
channeling over 70% of finances.
Some of the finances flowing through medical schemes are derived through government
sources. In 1998/99, at least 10.3% of medical scheme finances, or R2.8 billion in
1999/00 prices, were contributed by government as a subsidy to its employees. This is
of great significance for two reasons:
• Firstly, tax finances are being used to provide health care to civil servants at a much
higher cost than public sector care (the maximum monthly government subsidy is just
over R800, while public per capita funding of health care for those without medical
aid was just over R800 per annum in 1998/99). Thus government is becoming
increasingly concerned, from an equity and efficiency perspective, that civil servants
receive cost-effective care.
• Second, it is estimated that only half of civil servants who are eligible for the
government subsidy have chosen to take up medical scheme membership (Comel1,
McIntyre and Mbatsha, 2001). Given the existing burd~n on government of the
present subsidies, government is concerned about being able to sustain these
subsidies.
2.8. Private Health Care Providers
In South Africa private health care can be crudely divided into a large corporate private
for-profit hospital sector, and a smaller private not-for-profit sector which includes
workplace health services and non-governmental organisations. The private for-profit
hospital industry is by far the largest section ofnon-state hospital provision. It generally
does not employ its own health professionals. Doctors make use of facilities and bill the
health insurers separately.
The following table (Table 2.3) indicates the number of specialist clinicians in private
practice in 1998.
TABLE 2.3: PERCENTAGE OF PRACTISING CLINICIANS IN PRIVATE
PRACTICE BY SPECIALITY
Total number % private
Anaesthetics 764 75
Cardio-thoracic surgery 58 48
Cardiology 54 63
Community Health 77 22
Dermatology 119 66




Obstetrics & Gynaecology 6.36 65
Ophthalmology 243 60
Orthopaedics 413 69
ENT Surgery 197 64
Paediatrics 504 43
Pathology 448 60
Plastic Surgery 112 54
Psychiatry 345 55
General Surgery 489 48
Urology 133 58
All specialities 6134 59
General Practice 15376 45
Source: MASA Database 1998
The above table indicates the number of specialist clinicians in private practice. There
are 489 general surgeons in the country. 48% of these are in the private sector. This
can give an indication of the number of operations performed in the private sector, and
the urgent need to cut costs on certain surgical instrumentation. Laparoscopies are also
done often by gynaecologists, ofwhich 65% are in private practice.
2.8.1. The Importance of the Private Sector
Jane Goudge from the Centre for Health Policy in South Africa has the following to say
about the importance ofthe private sector and its link with public health provision:
The public and private sectors within health care are often perceived as two distinct
entities - a public sector providing care for the majority of the public, and a private
sector, providing care for the wealthy who are able to afford medical scheme coverage.
If the concern of the Department of Health is meeting the needs of the poorer majority of
the population, why should it be concerned with the private sector? Private providers are
primarily motivated by the aim of making a profit, and as a result their objectives do not
coincide with the public goal of providing universally acceptable health care for the
whole population.
This mismatch of objectives results in particular problems for health provision (Bennet
and Mills 1994). The problems are:
• the profit motive may override good clinical practice
• a failure to address public health issues, such as prevention
• a lack of integration with government health services
• attraction ofhealth professionals out ofthe public sector
• the provision of poor quality care, or inappropriate services and distribution of
facilities.
Goudge goes on to say that the government is unlikely to either ban the private sector
(politically unfeasible and practically impossible given government capacity), or ignore
it, given the impact of private sector provision on the public sector. The government's
response to the private sector has to have three aims:
• To plan for the impact ofchanges that are likely to influence the absolute and relative
distribution ofresources between the two sectors.
• To build constructive public-private partnerships from which the public sector can
benefit.
• To influence private sector behaviour through regulation - both in the form of
legislation, and through a framework of incentives (financial and non-fmancial). The
aim of regulation should be not only to limit the problems listed above, but to ensure
that the public health sector benefits from its interaction with the private sector, and
VIce versa.
The public sector could proactively use public-private partnerships as a means of
increasing the resources available to the public sector, enabling it to improve the quality
of care. Regulation would be crucial to ensure both that those using the private sector
receive a reasonable quality of care, and that the public sector benefits from public-
private partnerships.
In order to maintain and improve health care for all in South Africa there needs to be
closer co-operation between the private and the public health sectors. It is essential that
both sectors identify and examine the unique challenges facing them. Both need to
become more cost-efficient and effective. Future co-operation between these sectors
may introduce new opportunities and the private sector should not be considered in
isolation (Veliotes, Magennis and Brown 1993).
Veliotes, Magennis and Brown go on to say that world-wide technology is a major factor
driving the global medical inflation spiral. International developments in medicine result
in the ongoing discovery of new procedures and equipment that affect diagnostic and
treatment methods. Because the cost ofsuch technology usually tends to be substantially
higher than that of older technology, 'it often increases expenditure disproportionately.
This phenomenon is particularly prevalent in the private health sector in South Africa,
where modem technology is used by private hospitals to attract health care providers.
Since most sophisticated medical equipment has to be imported by South Africa, the
devaluation of the Rand against most major international currencies increases the cost of
technology.
2.9. Cost-effectiveness in General Surgery
Surgical training has a definite influence on the practice of surgery. Both are subject to
the governmental and market forces that are revolutionising the delivery of health care
today.
2.9.1. Surgical Training
Surgical education and practice are inextricably linked. Each is essential to the other's
existence, and what happens in one area inevitably affects the other (Stone and Doyle,
1996). Efforts to reduce costs impact profoundly on surgical practice and will therefore
have a significant impact on surgical education. Surgical educators need to adapt to
many changes in surgical practice while opposing some potential changes that may be
harmful to the learning process (Stone and Doyle, 1996). A balance must be struck.
Medical students must be exposed to the new economics of health care early in their pre-
clinical years. This will provide a fundamental understanding of the rationale for cost
efficiency. Business principles e.g. costing, margin, should be taught.
Managed health care plans aim to reduce costs by emphasising out-patient care and
decreasing hospital utilisation. Surgical lengths of stay have decreased dramatically in
the years between 1991 and 1996 and an increasing number of surgical procedures are
performed on an out-patient basis or in free-standing ambulatory surgery centres (Stone
and Doyle, 1996). Between 1980 and 1992 the average length of hospital stay for a
patient undergoing a cholecystectomy decreased from 10.9 days (Haug and Seeger, 1982)
to 4.9 days (Rogers, 1995). Thus surgical training must emphasise the importance of
reducing the length ofstays.
Malcolm Knowles (Knowles, 1980) is a premier theorist of adult education. He
acknowledged that educational goals in the real world must be filtered through the needs
of the institution and society as a whole. Health care institutions must define their
mission and the strength of their commitment to education. Cost of medical care is the
driving force behind the current changes in the surgical practice (Stone and Doyle, 1996).
2.9.2. Cost-effective Management of Gall-bladder Disease
These are times of world-wide economic retraction, therefore much interest IS now
focused on the money we spend on health care. Surgeons perform costly procedures; so
the health care system has focused on them and specifically on laparoscopy.
Laparoscopic technology has been explosive and unfortunately has come with increasing
equipment costs. On one hand surgeons have to deal with appropriate utilisation of
laparoscopy, and its additional impact on a surgeon's daily life through increased
operating time, increased risk to the patient and the provider, and increased cost to health
care from the incorrect utilisation ofpioneering procedures (Traverso 1996).
There is no doubt in anyone's mind that the advent of laparoscopic procedures has had
enormous benefits, both social and economic, for both surgeons and patients.
Laparoscopic cholecycstectomy used as a long-term solution to symptomatic gall-stone
disease has obvious advantages when compared to open cholecystecomy. These
advantages include:
• Shorter length ofhospital stay.
• Decreased post-operative morbidity.
• More rapid resumption ofnormal daily activities.
However, a study done by Legoretta et al suggested an overall negative economic impact
of laparoscopic cholecystectomy. This is partly due to increased patient demand for
these services. An informal survey done by Orlando III(1996) also showed that 17 of 19
gastro-enterologists stated that they had relaxed their criteria for referral of patients with
gallstones for surgery. Orlando III and Russel did a survey in Connecticut in 1996
which showed that the advent of the technique of laparoscopic cholecystectomy resulted
in a 29% increase in the overall rate of cholecystectomy. Similar increases were
reported in New York, Maryland and Pennsylvania. This increased rate is evenly
distributed over all age groups.
Due to these increases in the number of laparoscopic cholecystectomies now being
performed, the cost of these procedures needs to be carefully evaluated. The areas that
can be controlled by the surgeons relate to clinical care of the patient and selection of
appropriate instrumentation for the procedure. Attempts to reduce hospital charges must
focus on controlling length of hospital stay and supply charges, which include disposable
instrumentation (Orlando and RusseI1996).
The role of instrumentation costs in laparoscopic surgery has thus far been controversial.
Many authors have attempted to compare disposable instrumentation costs with re-usable
costs. A study done by MacFayden et al reported disposable instrumentation costs of
$806, compared with $503 for re-usable instruments. This included a $200 per case
reprocessing. charge for the re-usables.
Deloitte and Touche, a health care consulting firm, conducted a study in nine hospitals
across the United States. This study was requested by a disposable instrument
manufacturer. They concluded that the average cost per case was $740 for a mixture of
disposable and re-usable instruments, and $725 per case for an approach using only
disposable instruments. However, in this study, using the mix of disposables and re-
usables, costs as low as $501 per case were observed.
Voyles has demonstrated that low hospital charges can be achieved with a programme
that is organised around good re-usable instrumentation. In a German study, Lefering et
al documented reduced costs and no difference in outcome with the use of re-usable
instrumentation. Other surgeons have analysed the cost effectiveness of particular
instruments. Re-usable trocars have been suggested to have a cost advantage (Duppler,
1992). However, this advantage must be weighed against concerns about device wear
and dulling of the points (Orlando and RusseI1996). OrIando and Russel also go on to
say that the disposable multi-fire clip applicator is particularly expensive compared with
a re-usable single-fire clip applicator that takes no more than one minute to use.
Instrument processing costs must be evaluated with a view to instrument design. Many
newer re-usable instruments have features to permit ease of cleansing (Orlando and
Russel, 1996). Despite disposables manufacturers' alarms about sterility of re-usable
instrumentation, no evidence of infection or contamination exists assuming that standard
steam sterilisation has been used.
Orlando and Russel advocate a pragmatic analysis of each instrument. The most
important factor for the surgeon is the clinical suitability of the instrument. Once
clinically satisfactory performance is assured, hidden costs, in addition to acquisition
costs must be considered in assessing re-usable instruments. Hidden expenses include
costs for repair, processing, replacement and back-up requirements. An assessment of
the useful life of the instrument is also necessary. These factors vary depending on the
instrument. In the experience of Orlando and Russel grasping forceps have a life of200
cases. Re-usable scissors (endoshears) have a much shorter life-span. Orlando and
Russel have adopted hybrid re-usable scissors with disposable tips. These tips last for 5
- 10 procedures after which they are discarded. De Vos et al supported the use of re-
usable and hybrid instrumentation in an abstract written in 1999.
The three specific laparoscopic instruments that this study will focus on are:
• Clip applicators.
• Endo-shears / Scissors.
• Trocars.
Much has been written and said about which type of laparoscopic trocar should be used.
Although individuals surgeons may have preferences, there does not appear to be any
great difference between the conical- and pyramidal-tip trocars, as long as they are sharp
(Duppler, 1992). Several types of disposable trocars are available as well. These are
routinely sharp and often come with a safety shield, which is said to decrease the risk of
intra-abdominal injury. It is important that these safety shields do not lull the surgeon
into a false sense of security, however, as injuries can still occur despite their use.
2.10. Re-sterilisation of Disposable Laparoscopic Instruments.
K. M. Ulualp et al conducted a study in 1999 on whether it is possible to re-sterilise
disposable laparoscopy trocars in a hospital setting. Disposable instruments have a
relatively more complex design than their re-usable counterparts, and the study was
undertaken to investigate the safety of hospital disinfection of disposable laparoscopic
trocars. Although the pharmaceutical companies that manufacture these disposables
have adamantly maintained that single use devices (disposable devices) are not to be re-
sterilised, this practice is occurring regularly in some hospitals. This is probably due to
the high cost of the disposable instruments, and the increasing number of patients
undergoing laparoscopic procedures. The result of the above study showed that
disinfection for multiple use of disposable laparoscopic instruments with a relatively
complex structure is not effective and may result in nosocomial disease transmission by
bacteria, fungi and viruses.
The above study appeared in the journal "Surgical Laparoscopy, Endoscopy and
Percutaneous Techniques, Volume 10, no.2" in 2000. Maurice E. Arregu~ one of the
editors of the journal wonders why this question even has to be asked. He goes on to say
that when many of these devices were originally developed, the medical economy was
quite different. Hospitals were able to make a profit on disposable devices. They
marked up the cost by a factor of 2.5, and encouraged surgeons to use these devices.
The argument of the hospitals at the time was that the use of re-usables was costly
because of the added work of cleaning and re-sterilising. It was also maintained that re-
usable instruments were not as safe as disposable instruments because of the risk of
injury to the bowel or blood vessels. Eventually there was no incentive for
manufacturers to make re-usable instruments.
Surgeons were also encouraged to use the disposable trocars because of the supposed
increased safety from the safety shield included in some of these disposable devices.
Surgeons became afraid not to use the disposable devices because they had become the
standard ofcare, and most feared that if a viscus or vessel injury occurred, they would not
stand a chance in a court oflaw. We now know that there is very little merit to the safety
shield; it has not prevented serious injury, and its use will not protect against litigation if
an injury does occur.
Arregui goes on to say that in his own practice, he does not use disposable trocars,
disposable clip applicators, disposable tackers or disposable balloons. He has saved
several hundreds of dollars on laparoscopic cholecystectomies. In his practice sterility,
safety and efficacy were not affected. In 1992, the cost of disposable trocars versus re-
usable trocars for laparoscopic cholecystectomies would cost $162 million annually
based on 500 000 cholecystectomies performed in the United States alone.
2.10.1. Why Hospitals Try to Sterilise Disposable Trocars
The medical economy since the beginning of the laparoscopic era has changed
dramatically. Because of the increased health costs in the United States there was a risk
that Medicare would go bankrupt, thus the US government and health insurers have
stopped paying line-item billing. Hospitals are getting paid a fIxed amount for a
particular surgical procedure. There is no incentive in the US now to use disposable
devices because the expenses and the mark-up are no longer paid for and there is no
profit margin. In the US, many companies have developed which reprocess disposable
devices. This has been allowed by the US Food and Drug Administration (FDA), but
now there is concern that many ofthese devices are not suitable for reprocessing. There
are the issues of sterility .and also of the potential degradation of products, which may
dislodge or malfunction ifrepeated sterilisation is performed. In the US the tide has now
changed back to using re-usable instruments.
In countries other than the US, the price of disposable instruments is double or more of
that in the US. These countries have economies that are not as good as that of the US,
thus the cost considerations of laparoscopic procedures is much more significant.
Therefore it IS not surprising that in these countries disposable instruments are re-
sterilised.
The manufacturers of disposable trocars have no practical economic reason to stop
making these disposable products. If they did, their profits would rapidly decrease.
Arregui does blame these companies for marketing to surgeons and convincing them that
it is unsafe to use trocars without a protective shield. He also blames the hospitals for
promoting the disposable trocars because it was profitable for them to do so. As long as
there is a market for disposable trocars, there will continue to be manufacturers. This
makes economic sense, although it may not make sense for medical and medico-
economic purposes.
2.10.2. Why Disposable Laparoscopic Instruments should not be Re-used
Carol Scott-Connor says that re-usable medical devices are designed to be cleaned
mechanically, and then sterilised or subjected to high level disinfection. A re-usable
metal trocar is easily taken apart and cleaned. A disposable trocar cannot be dismantled
for thorough mechanical cleansing, yet this cleansing is the crucial ftrst step toward
effective infection control. Blood or other tissue fluids that remain in inaccessible
crevices of these devices significantly impede the efficiency of disinfection. Even ifone
could assure mechanical cleansing, any sterilising or disinfecting agent must contact all
surfaces ofa device to work properly.
In a study done by H. Gundogdu et al in 1998, a positive bacterial culture was obtained
from one of thirty disposable trocars subjected to high-level disinfection with
gluteraldehyde. Laparoscopy has been in use for decades and there is no known case of
infection transmission by laparoscopic instruments that have undergone proper cleansing
and steam sterilisation.
Additional concerns arise when instruments designed for single use are re-used. The
electrical insulating material is not designed for multiple use. Mechanical fatigue may
produce instrument failure.
2.11. Quality in Health Services
A focus on quality in health services has been developing world wide in the last two
decades (Gary Morris, SAHR 1999). Efforts to improve quality are slowly coming
together in a type of quality movement throughout South Africa. The focus on quality
has its origins in Japanese industry in the 1950s.
The dimensions ofquality generally taken as the most important are:
• Interpersonal relationships
• Access to service
• Effectiveness
• Consistency and continuity ofservice
• Efficiency
• Technical competence ofthe provider
• Safety
• Comfort and amenities.
Modem thinking recognises the need for a quality workforce with a clear vision of what
the quality movement entails, and an explicit commitment to that vision. The Balanced
Scorecard is one tool that can assist in integrating various aspects of the service. It
measures core business across four inter-linked quadrants:
• Starting from needs and services to be provided for the client, then...
• Setting up systems and processes to provide those, then...
• Developing the human resources in terms ofknowledge, skills and attitudes, then...
• Determining the financial needs and getting the most out ofthe financial resources.
The following figure (Figure 2.5) is a diagrammatic representation of the Balanced
Scorecard.
Figure 2.5: The Balanced Scorecard (Source: SAHR 1999)
Financial Systems and Processes
lIurnnan esources
2.12. Conclusion
The public and private sectors in the health care industry are often regarded as two
separate entities - a public sector which provides care for the majority of the population,
and a private sector that provides care for the wealthy who are able to afford medical
scheme coverage. But as can be seen from the previous discussion, these two sectors are
inextricably linked.
In order to improve health care for all of South Africa's population, there must be closer
co-operation between the private and the public health sectors. Both sectors have to
identify and examine all the challenges facing them. Both need to become more
effective and cost-efficient.
Veliotes, Magennis and Brown suggest that world-wide advances ill medicine and
technology is a major factor that is driving the global inflation spiral. The cost of this
technology is usually far greater than that of the older technology. This often increases
health care expenditure disproportionately. This price increase is particularly prevalent
in South Africa where modern technology is used by private hospitals to attract health
care providers.
Laparoscopic procedures have undoubtedly had enormous social and economic benefits
for both surgeons and patients. Because ofthe explosive increase in the number of these
procedures now being performed, costs of these operations have to be carefully
evaluated. The areas that can be controlled by the surgeons relate to the clinical care of
the patient, and selection of appropriate instrumentation for the procedure (Orlando and
Russel, 1996).
The main driving force behind the selection of laparoscopic instrumentation is economic.
The manufacturers of disposable laparoscopic instruments have no sound economic
reason to stop making disposable devices. In the same vein, because of economic
reasons, the dangerous practice of re-sterilising single-use devices at some hospitals is
becoming more rampant. There is no clear evidence thus far that re-usable laparoscopic
instruments are in any way inferior to the disposable ones. The usual documented
complications following laparoscopic cholecystectomies have no direct link to the type of
instrumentation used.
CHAPTER 3: CASE STUDY
3.1. Background Information
KZNGOV Hospital was opened approximately 65 years ago in Durban. This is a
fictitious name for the purposes ofconfidentiality in this study. Its original purpose was
to provide general medical care for Indian and Black patients, as this was not adequately
provided for by the existing provincial hospitals. The hospital originally comprised two
large separate blocks of general wards. In addition to these blocks were the
administrative block, a theatre complex, an X-ray department and surgical and medical
outpatient facilities.
Upon opening, the hospital was functioning as a 720- bed hospital, but this bed space was
rapidly outgrown because of the burgeoning population in the Durban area. This
increase in population growth was due to deteriorating conditions in the rural areas and
rapid industrialisation. The following table shows how fast the hospital expanded in the
early years:
Table 3.1: Patient Statistics at KZNGOV Hospital between 1937 and 1950.
Year 1937 1940 1944 1950
Average no. ofoccupied beds 500 820 1100 1 636
Patients admitted 13 350 27125 36345 45447
Outpatients 29100 69000 302315 415293
Births 300 2000 3520 6347
Source: Golden Jubilee Brochure KZNGOV Hospital
There were many crises in the 1940s: the Second World War (1939 - 1945), the smallpox
epidemics, the poliomyelitis epidemic and the 1949 riots. These increased the pressures
on the hospital. During the war, extra bed space was required by the military authorities.
Five new prefabricated wards were constructed which were still in use until about three
years ago. Other temporary structures were also created to alleviate the fast growing
maternity section. Further outpatient facilities were created away from the hospital to
meet the growing demand for health care provision.
In 1947 the establishment ofa medical school in Durban under the aegis of the University
of Natal was approved in principle by the cabinet. Treasury approval was only granted
in 1950. The medical school opened in 1951 and clinical training of the first group of
students commenced in 1955. KZNGOV Hospital was then established as a teaching
hospital. The establishment of the medical school was an extremely important
development as, until this time, few black medical students were given places in the
existing medical schools in the country, and many were forced to train overseas.
With the inception of the medical SCh004 a major expansion of the hospital building
programme commenced. A complete new surgical block, a new outpatients and casualty
block, operating theatres and a fully equipped x-ray department were built. The
maternity department was also extended. The original intended complement for this
hospital was 720 beds in 1936, and it had now grown to a registered bed state of more
than 2000. The following table shows the hospital's growth as reflected by admission
statistics:
Table 3.2: Admission Statistics at KZNGOV Hospital between 1937 to 1980
1937 1940 1950 1960 1970 1980
Patients Admitted 13 350 27125 45447 70572 93599 106993
Outpatients 29100 69000 415293 558 146 673433 835606
Births 300 2000 6347 13 908 20090 21221
Source: KZNGOV HOSpItal Golden JubIlee Brochure
The creation ofa medical school also brought about other changes at KZNGOV Hospital.
From a purely service type of hospital, the emphasis now changed to teaching as well as
servIce. Members of the staff of the Faculty of Medicine have made valuable
contributions to medical research and to the advancement of medical knowledge over the
years. The medical school and its teaching hospital are highly regarded in South Africa
and abroad.
The teaching complex generated a progressive change in medical and scientific
technology. Specialist expertise evolved and specialist departments and sub-disciplines
evolved, e.g. orthopaedics, ophthalmology, ENT, urology, neurosurgery and paediatric
surgery. Each of these specialities was under the charge of a surgeon of professional
rank.. With the creation of the various sub-specialities more work was generated and
patient flow to the hospital increased. Since the hospital could not be physically
expanded, existing beds and square -footage in outpatient departments had to be shared.
More general as well as specialised nurses were needed, and the number of doctors had to
be increased considerably. The numbers of undergraduate medical students also
increased, and this added to the congestion everywhere in the hospital. Later
paramedical training in such fields as physiotherapy, radiotherapy, nuclear medicine,
ultrasound, pharmacy, speech and occupational therapy and medical technology was well
established in the hospital.
Over the years the increase in patient numbers overwhelmed available facilities to an
extent that patients used to sleep on mattresses at night. The daily average of 150 "floor
beds" greatly reduced physical ward space and increased cross-infection. It also added a
considerable burden on the nursing staff. Thankfully this is not the case any more.
These floor beds caused an urgent need to increase service needs such as catering,
laundry, maintenance, laboratories, mortuary, central sterilising and the internal
communicating system.
Today, with the opening of the Inkosi Albert Luthuli Hospital in Cato Manor, KZNGOV
Hospital is in a process of decommissioning. Many of the specialist departments have
moved over to the new hospital, and KZNGOV Hospital will be re-graded as a regional
and not a tertiary hospital. However, the main departments e.g. general surgery, internal
medicine and obstetrics and gynaecology will remain.
3.2. Surgical Technique of Laparoscopic Cholecystectomy
This section will not describe in detail the exact methods and technicalities ofperforming
a laparoscopic cholecystectomy, but will concentrate mainly on the instruments that are
being investigated in this study and their respective uses.
3.2.1. Exposure of the Peritoneal Cavity and its Contents
The patient is positioned on the operating table in a supine position i.e. the patient is lying
on hislher back. This position is used to create the pneumoperitoneum (air in the
peritoneal cavity) and it also allows for manipulation of the small and large bowel.
When a view is required of the stomach, liver and spleen, a head-up tilt of the operating
table allows the bowel to move inferiorly (downward) by gravity. Care must be taken to
stabilise the patient on the table during any tilting away from the horizontal. The
stomach is decompressed by means of a nasogastric tube. This decompression serves
three purposes:
• Accidental penetration ofthe stomach is less likely.
• Visualisation of the gall-bladder, liver and the free edge of the lesser sac of the
stomach is easier.
• When anaesthesia is reversed the risk of vomiting due to a bloated stomach IS
decreased.
3.2.2. Insufflation of the Peritoneal Cavity
Carbon dioxide is the standard gas used for most operative laparoscopy, mainly because
it does not support combustion. After absorption from the peritoneum it is readily
excreted via the lungs. If carbon dioxide is accidentally injected into a blood vessel
resulting in carbon dioxide embolism, this is more easily treated than air or nitrous oxide
embolism.
Optimum exposure is obtained with a constant pneumoperitoneum of 12.0 - 16.0 mmHg
pressure. Because operative laparoscopy entails the use of multiple cannulae and the
frequent changing of instruments, there is intermittent gas leakage throughout the
procedure. This problem has been resolved by the introduction of the automatic
electronic insufflator. This insufflator is capable of automatic flow rates of up to 8.0
litres/minute. Operative procedures without this machine are tedious and time
consuming. The insufflator also provides good monitoring of the pressure within the





3.2.3. Placement of the Veress Needle
The initial induction of the pneumoperitoneum is still most often performed with the
Veress Needle. It consists of a sharp outer sheath and a blunt spring-loaded inner
cannula which helps protect intra-abdominal organs from injury (Cuschieri, 1984). The
spring-loaded central trocar retracts as the needle encounters resistance, and retracts back
on entering the peritoneal cavity. The function of the spring-loader snap mechanism
should be confIrmed prior to initial insertion, as should the patency of the lumen of the
needle. This is done by checking gas flow through it. The Veress needle is most often
inserted just below the umbilicus. This is where the laparoscope trocar and cannula will
be inserted. The following is an example ofa Veress needle.
Fig.3.2: The Veress Needle
Source: Storz Catalogue
3.2.4. Insertion of Initial Trocar/Cannula
The site for insertion of the first trocar is usually around the umbilicus. This first trocar
should have an external diameter of 11.Omm and is used to hold the video laparoscope.
The Veress needle is withdrawn and the skin incision used for the Veress needle is
extended to 1.5cm. The trocar/cannula is then inserted into the incision. As soon as
complete penetration of the abdominal wall is achieved by the trocar, one gets a sudden
escape of intra-peritoneal gas. The trocar is then removed and the cannula is advanced
further into the abdomen. The gas line is then connected to the side port of the cannula
and the tap opened to maintain insufflation ofthe peritoneal cavity.
3.2.5. Insertion of Accessory Trocars / Cannulae
The accessory trocars / cannulae are usually 5.0mm and 1O.Omm in diameter. These are
required for the insertion or withdrawal of the various laparoscopic instruments. In the
majority of patients three accessory cannulae are needed. The French technique places
these three accessory cannulae in the following positions:
• A 1O.Omm cannula is placed in the upper left paramedian area; this port is used for
the electrosurgical hook knife, scissors.
• A 5.0mm cannula is placed in the upper medial subcostal area; this port is used for
retraction oforgans, suction and irrigation.
• A 5.0mm cannula is placed in the lower right hypochondrial region; this port is used
for the grasping forceps.
The techniques for dissecting out the gallbladder and removing it will not be discussed
as there is too much surgical technical detail involved. However, we will be discussing
the other two instruments that are under consideration in this study, namely the
endoshears / scissors and the clip applicator.
3.3.Instroments Under Consideration in this Study
The three instruments that are going to be considered in this study are:
• Trocars and cannulae
• Endoshears / Scissors
• Clip applicator
3.3.1. Trocar/Cannula
A trocar is an instrument which is inserted into a body cavity through which the
laparoscopic instruments are inserted. It comprises an outer tube containing an inner
removable shaft that has a sharp point. The shaft is withdrawn after the trocar has been
inserted into the body cavity. The trocars used today can be either re-usable or
disposable. The re-usable trocars are made of stainless steel. These instruments are
sterilised by steam using an autoclave. The disposable instruments are strictly for single
use only and made of a plastic material. The following figures show the disposable and
the re-usable trocars within and separate from their sleeves / cannulae.
Fig. 3.3: Disposable Trocar with Sleeve Removed
Source: KZNGOV Operating Theatre
Figure 3.4: Disposable Trocar in Sleeve
Source: KZNGOV Operating Theatre
Figure. 3.5: Re-usable Trocar with Sleeve Removed
Source: KZNGOV Operating Theatre
Figure 3.6: Re-usable Trocar within Sleeve
Source: KZNGOV Operating Theatre
3.3.2. Endoshears / Scissors
The endoshears or scissors are used for tissue dissection. As in open surgery, various
methods of dissection along tissue planes are used. As every minor blood loss
considerably impairs VISIon during laparoscopic surgery, a meticulous bloodless
dissection is essential. There are six types ofdissection used:
• Blunt dissection with a "peanut" swab, or hydro-dissection with a pressurised jet of
warm saline.
• Sharp dissection using scalpels ofvarious sizes and shapes.
• Scissors or endoshears dissection.
• High frequency electrosurgical dissection with monopolar current.
• Laser dissection.
• Ultrasonic dissection.
Endoshears or scissors dissection is used commonly. Recently there has been significant
progress in the design, size and type of scissors for laparoscopic work. Scissors, in terms
of the mechanical function are either single- or twin-action. The former have only one
moveable blade, and in the twin variety both blades move. A large blunt-nosed scissor is
available for use with the II.Omm cannula. Figures 3.7 and 3.8 show the disposable and
re-usable endoshears / scissors respectively.
Figure 3.7: Disposable Scissors / Endoshears
Source: KZNGOV Operating Theatre
Figure 3.8: Re-usable Scissors I Endoshears
Source: STORZ Catalogue
3.3.3. Clip Applicators and Clips
Clips are used to secure haemostasis during the operation. Control ofbleeding is usually
more difficult in laparoscopic surgery than in open surgery. Clips are usually used to
clamp blood vessels ofbetween 3.0mm and 5.0mm in diameter.
The non-absorbable metal clips are made of stainless steel or titanium, and are available
in different sizes. Clip applicators are available in two sizes - one for clips of 6.0mm in
length, and one for clips of 9.0mm in length. Application of clips must be done
carefully, and a second clip should be used on the proximal section of the artery.
Disposable preloaded clip applicators with automatic delivery of the clip to the jaws of
the applicator are useful for long procedures and do have certain advantages. These
instruments allow for rapid, precise, repeated clipping without the need of withdrawal of
the instrument for loading. This speeds up the procedure quite considerably. But these
instruments are costly and are not essential for routine cholecystectomy.
The current limitation ofall clip applicators (disposable and re-usable) relates to the fixed
size clip that each instrument can apply. This entails the use ofdifferent clip applicators
for small, medium and large clips. This is an important practical consideration because
clip security after application is dependent on using the appropriate size of clip in relation
to the occluded vessel. The risk of slippage is especially high if the clip is too small and
does not project beyond the whole width of the vessel, or is not applied at right angles to
its long axis. Accidental brushing or traction can also result in the slippage ofclips.
Figure 3.9: Re-usable Clip Applicator
Source: STORZ Catalogue
Figure 3.10: Tip of Re-usable Clip Applicator showing a Titanium Clip Below
Original Size
Source: STORZ Catalogue
Figure 3.11: Disposable Clip Applicator
Source: KZNGOV Operating Theatre
3.4. Disposable and Re-usable Instruments
Almost all laparoscopic instruments are now available as disposable items from several
well established and many newer companies, with the exception of optics. There are
obvious advantages that are inherent to disposable products. The disposable instrument
when used is guaranteed to be at its peak functional state, and therefore the risk of
malfunction is decreased. This is undoubtedly an important consideration, especially
when it applies to complex instrumentation such as disposable cartridge staplers and pre-
loaded clip applicators. However, when it is extended to the more common instruments
there are practical disadvantages that must be taken into consideration. These
disadvantages are:
• The increasing cost - this is directly proportional to the number of disposable items
used per case.
• The disposable instruments create additional problems for the hospital by increasing
the administrative task of ordering, inventory and storage. An adequate stock of
disposable equipment to cover all contingencies is essential for a successful practice
and to ensure the uninterrupted progress of laparoscopic operations.
• Human nature being what it is contributes to the risk that disposable equipment will
be cleaned, sterilised and re-used a number of times. This is a dangerous practice
and the ability of these disposable items to be cleaned is limited, and cleaning causes
their functional performance to deteriorate rapidly. They are safe and reliable ifonly
used once.
• The ecological consequences inherent to the disposal of the plastic material are real
and will assume increasing importance.
With regard to the common laparoscopic instruments e.g. graspers, scissors and hooks, a
good re-usable instrument is much cheaper in the long run, even if additional manpower
and time are needed for maintenance, cleaning and sterilisation. We now have the
development of semi-disposable instruments, where the functional part is disposable, but
the rest of the instrument is re-usable.
3.5. Sterilisation and Disinfection
Medical instruments to undergo sterilisation and disinfection are divided into three
categories based on the degree of risk of infection involved in the use of these items:
Critical, semi-critical and non-critical.
• Critical items are those entering sterile tissue or the vascular space, such as
laparoscopic instruments.
• Semi-critical items are those that come into contact with skin that is not intact, or with
mucous membranes, e.g. gastrointestinal endoscopes and respiratory therapy
equipment.
• Non-critical items come into contact with skin only e.g. blood pressure cuffs.
Ideally, critical items such as laparoscopic equipment should be sterilised. If this is not
feasible, however, high level disinfection may be appropriate.
3.5.1. Sterilisation
The term "sterile" refers to the inability of living organisms to reproduce.
micro-organisms is synonymous with death because their activities




organisms are also termed sterile. The presence of a single mico-organism renders an
article unsterile.
Sterilisation is a process that kills or removes all types of micro-organisms, including
resistant bacterial spores. It is impossible to guarantee that every micro-organism
exposed to a particular treatment has been killed or that every article has been sterilised.
Thus, realistically, sterilisation is defined as a process that provides an acceptably low
probability (e.g. one chance in a million) that any micro-organism will survive the
treatment.
It is important to know when sterilisation, which may involve severe treatment of
equipment and materials, is required. It is essential for articles that enter the blood or
tissues, e.g. surgical instruments, syringes, needles and solutions for intravenous infusion
or injection. Diagnostic instruments that come into contact with delicate mucous
membranes, like those lining the urinary tract or peritoneal cavity, should also be used in
a sterile condition.
3.5.2. Disinfection
A disinfection process is intended to kill or remove pathogenic (disease-producing)
micro-organisms with the exception of bacterial spores. Spores can be killed only by a
sterilisation process. Terminal disinfection of used equipment which may be
contaminated with harmful micro-organisms IS commonly referred to as
"decontamination". Antisepsis is not synonymous with disinfection; this term should be
reserved for the prevention of infection by topical application of anti-microbial agents to
injured tissue.
Disinfection is divided into three levels depending on the amount of micro-organisms
eliminated:
• High level- eliminates all organisms with the exception of large numbers ofbacterial
spores.
• Intermediate level - destroys all organisms except spores, some viruses and some
fungi.
• Low level - can destroy most bacteria and some fungi, but cannot eliminate spores or
tuberculosis bacilli.
Disinfection is adequate for the preparation of many articles intended for use in patient
care. These include bedpans, urinals, clinical thermometers and eating and drinking
utensils. Floors, walls, tables, trolleys and work benches require disinfection as well as
cleaning ifcontaminated with blood, tissues, exudates or microbial cultures has occurred.
Disinfection by chemical agents is the only method applicable to the skin of hands,
operation sites and injection sites for killing transient contaminants or reducing the
resident microbial flora to a low level.
Disinfection by pasteurisation, boiling or chemical agents does not make surgical
instruments safe to use. Its use as a substitute for sterilisation cannot be justified. When
this is unavoidable because a costly instrument, in short supply, is heat sensitive and
insufficient time is available for the slower process of gas sterilisation, a broad spectrum
disinfectant should be chosen. An example of a broad spectrum disinfectant is
gluteraldehyde. However, the person responsible should be fully aware of the risk
involved.
3.6. Essential Pre-requisites for Sterilisation and Disinfection
The efficiency of sterilisation and disinfection depends on:
• Biocidal action
• Effective contact between the biocidal agent and the micro-organisms
• Appropriate biocidal agents and apparatus
• Severity oftreatment.
3.6.1. Biocidal Action
Biocidal action implies the death of micro-organisms, as indicated by their failure to
multiply in any situation. It must be distinguished from reversible inhibition of
multiplication (biostasis), from which the organisms may recover on return to favourable
conditions. Biocidal action is essential for sterilisation and disinfection. A biocidal
agent is one that is capable ofkilling micro-organisms. The term is sometimes restricted
to agents that kill all types of micro-organisms but is also used in a less exact sense to
imply that some organisms are killed. Biocidal action against micro-organisms of a
specified type is termed bactericidal, sporicidal, virucidal or fungicidal.
3.6.2. Effective Contact
Effective contact between a biocidal agent and its microbial target requires penetration of
the physical or chemical agent to all sites at which the organism may be located.
a. Saturated Steam
Steam under pressure reaches the outer surfaces of solid objects and penetrates into
accessible cavities and packed cotton textiles if the air has been completely removed. It
cannot penetrate into non-aqueous liquids or impervious solids. Effective contact
involves condensation to water. The latent heat that is released brings the articles rapidly
to the sterilising temperature and the film of moisture ensures that conditions are optimal
for biocidal action. Wrapping materials must be permeable to steam and also to the
removal ofair. In sterilisers that rely on gravity for the downward displacement of air by
steam, the articles must be packed and loaded to facilitate drainage ofthe heavier air from
trays, bowls, tubes and textiles. Flexible tubes should not be tightly coiled.
b. Gaseous Chemicals
Gas sterilisation by ethylene oxide requires penetration of the chemical agent and also of
water vapour, which is essential for biocidal action. Ethylene oxide is highly diffusible,
passing through many materials including thin polyethylene films.
c. Dry Heat
Dry heat sterilisation does not involve penetration of vapours but the articles must be
heated to the sterilising temperature by conduction or convection. Metals are good
conductors, but glass and oily materials are poor conductors ofheat.
d. Ionising Radiation
The penetrating power of sterilising radiations depends on the type of radiation and the
energy level. Electromagnetic gamma radiation penetrates deeply into large cartons
containing materials of unit density. Accelerated electrons have greater energy than
gamma radiation but less penetrating power because they are particulate.
e. Chemical Disinfectants
Effective contact between the solutions and the articles to be disinfected depends on the
nature ofthe articles and the condition ofthe micro-organisms. Contact is unlikely to be
achieved if the micro-organisms are located in pores or crevices or are protected by
hardened deposits of organic or crystalline material. The complex, lipid-rich cell walls
of Gram-negative bacteria, especially Pseudomonas species, present a barrier to the entry
of some bactericidal agents into the cells. The wetting power of disinfectants is
enhanced by alcohol or detergents.
3.6.3. Appropriate Agents and Apparatus
Biocidal agents that are used for sterilisation are listed with main applications and
sterilisers in the following table: (Table:3.3).
Table 3.3: Biocidal Agents for Sterilisation
Source: IntroductIon to SteriliSatIon and Disinfection
Agent Applications Apparatus
Saturated Steam Wrapped articles Prevacuum steriliser, 134°C
Unwrapped instruments and Downward displacement
utensils steriliser, 132-134°C
Aqueous liquids Downward displacement
steriliser, 121°C
Dry Heat Metal articles, glassware, Hot air oven, 160°C
oils
Gaseous Chemicals Heat-sensitive instruments Ethylene oxide steriliser or
and medical devices Low temperature steam and
formaldehyde steriliser
Ionising Radiation Medical devices 60CO installation or
Electron accelerator
..
Physical and chemical agents ofdisinfection are listed in the table that follows:
Table3.4: Biocidal Agents for Disinfection
Source: IntroductIon to SterilISatIon and DIsinfectIon
Agent Applications Apparatus
Hot Water Heat sensitive instruments Temperature-controlled
Anaesthetic apparatus water bath, 7SOC
Blankets and linen Washing machine, 7SoC
Mop heads
Eating and drinking utensils
Low-temperature steam Heat-sensitive instruments Low-temperature steam and
formaldehyde steriliser
(without the formaldehyde)
Ultraviolet Radiation Room air Germicidal lamps
Formaldehyde Vapour Contaminated rooms Electrical vaporiser








Pressure steam sterilisers are specially designed for porous loads (comprising all wrapped
articles), unwrapped instruments and utensils, or aqueous liquids. Prevacuum sterilisers,
with mechanical air remova~ are required for efficient sterilisation ofporous loads. The
downward displacement type may also be used but is more liable to error and the cycle is
longer. Downward displacement steam sterilisers should be used for unwrapped
instruments and utensils and also for bottled liquids. The provision of a spray-cooling
system for liquids reduces the time required for sterilisation and mmumses the
deterioration ofheat-sensitive ingredients.
b. Gas Sterilisers
Sterilisers for heat-sensitive equipment are designed for the removal of air by mechanical
evacuation, vaporisation of the chemical agent (ethylene oxide or formaldehyde) and
maintenance ofthe relative humidity required for biocidal action.
c. Dry Heat Sterilisers
Dry heat sterilisation is usually carried out in hot air ovens with forced air convection.
Direct flaming is used to sterilise some laboratory bench tools such as inoculating loops.
Incineration of waste material is also a form of dry heat sterilisation; the design of
incinerators is critical as live micro-organisms escape with the effluent if burning is
incomplete.
d. Radiation Installations
Radiation sterilisation is virtually restricted to industrial installations because of the
complexity of the equipment and the essential safety precautions. A Cobalt-60 (60CO)
gamma radiation source or an electron accelerator may be used.
e. Chemical Disinfectants
Chemical disinfection does not require complex apparatus. Containers should be of
suitable shape and size and filled with sufficient solution to ensure that the articles are
completely immersed and that cavities are free from trapped air. The selection of an
appropriate disinfectant is based on its range and degree of bactericidal activity
(determined by an approved method), its compatibility with the articles to be disinfected
and other materials with which it may come into contact during use.
f. Bacterial Filtration
The physical removal of bacteria from liquids and air is accomplished by filters of
appropriate pore diameter and retention efficiency. Suitable filter holders and other
accessories are required. Membrane filters that have an average pore· diameter of
0.22J.1m or 0.45J.1m and act as mechanical sieves are most suitable for filtration of liquids.
Fibrous filters have a greater bacterial load capacity but the flow rate is low and the
quality of the solution may be affected by adsorption of solutes, alteration of pH or
addition of fibres. Fibrous filters in the form ofpacked columns or thin paper sheets, are
commonly used for air filtration, but membrane filters are suitable for some applications.
The fibrous sheets have a large surface area and are used in conventional or laminar flow
ventilation systems. Each sheet is pleated and all the edges are sealed into a frame to
form a compact unit.
3.6.4. Severity of Treatment
Heat sterilisation processes are defined by time at a specified temperature.
Recommended times for steam sterilisation are 15 minutes at 121°C and 3 minutes at
132-134°C. These represent the minimum holding times for which the whole of the
material treated must be held at the selected sterilising temperature to kill the microbial
contaminants. They are based on the resistance ofBacillus stearothermophilus spores to
moist heat. In dry heat sterilisation, a holding time of60 minutes at 160°C allows for the
possibility ofa 10°C variation in temperature within the oven.
The parameters of a gas sterilisation process are more complex. The conditions required
for sterilisation in a hospital ethylene oxide process operated within a temperature range
of45°C - 60°C are:
• Ethylene oxide: 400 - 1000 mg/litre
• Relative humidity: 70%
• Time: 4 hours.
A radiation sterilisation process is described by a single value, the minimum absorbed
dose. A minimum dose of 25kGy (2.5 Mrad) is commonly used in the commercial
production of medical devices but is increased if the contamination level of the articles
exceeds the level for which the dose has been calculated.
The efficiency of chemical disinfection depends on the concentration and the time for
which the solution is in contact with the articles or surfaces to be disinfected.
3.7. Procedure at KZNGOV Hospital's Operating Theatre
Approximately four to five laparoscopic cholecystecomies are performed at KZNGOV
Hospital per week. Many other laparoscopic procedures are also done e.g. by the
gynaecologists and the urologists. Specially packed sterilised sets are reserved for the
general surgeons doing the laparoscopic cholecystectomies. These sets comprise mainly
re-usable instrumentation, except for the fibre-optic instruments.
The general surgeons at KZNGOV Hospital use the three-port technique to perform the
laparoscopic cholecystectomy. One 5.0mm trocar and two 11.0mm trocars are used.
Using the Veress needle a pneumoperitoneum is created with carbon dioxide. This is
maintained at a pressure of 15mmHg. The cystic duct is usually first identified and
secured with two clips, after which it is divided. Two clips are also used to ligate the
cystic artery. The gall-bladder is then dissected ofIthe gall-bladder bed using blunt and
scissors dissection. It is then removed through one of the accessory ports. The
abdominal cavity is checked thoroughly for any bleeding. Any gall-stones that have
fallen out of the gall-bladder are retrieved as well, and haemostasis is secured. The
abdominal cavity is then washed out with sterile normal saline and the rectus sheath and
skin are sutured.
The professional theatre sister who is the mam scrub nurse for the laparoscopic
cholecystectomy is solely responsible for cleaning, packing and caring for the
instruments. The re-usable trocars, endoshears and clip-applicators are carefully and
thorougWy cleaned after each laparoscopy with water and special custom manufactured
brushes. These brushes are specially made to fit into the cannulae and to access all
crevices on the instrument. Cleaning is thorough, and all visible organic matter like
blood or tissue and other debris are carefully removed. The instruments are then re-
packed and sent to one ofthe large autoclaves in theatre for steam sterilisation.
In KZNGOV Hospital theatres, the 11.Omm and the 5.0mm trocars are used. These are
re-usable instruments made from stainless steel. The scissors used are of the hybrid
variety. They comprise a stainless steel autoclavable handle, and black disposable tips.
The handles are steam-sterilised and the disposable tips are sterilised with ethylene
dioxide. This is after thorough mechanical cleansing. The disposable tips are used
approximately five times then discarded. This practice is similar to that employed by
Orlando and Russel in their practice in the United States of America. The clip
applicators used at KZNGOV Hospital are also of the re-usable variety, and are cleaned
and autoclaved like the rest of the instruments. They are used with pre-packed titanium
clips that are sterilised at the manufacturing facility by means of gamma radiation.
These clips come in a cartridge of eight clips. This is usually sufficient for one
laparoscopic cholecystectomy.
The theatre committee has found that the above protocol for dealing with laparoscopic
instruments to be the most cost-effective one thus far. In a government hospital, or in
any other for that matter, one cannot afford to waste the dwindling financial resources.
The protocol used at KZNGOV Hospital is similar to that used by Arregui in his practice.
Arregui is the editor of the American journal "Surgical Laparoscopy, Endoscopy and
Percutaneous Techniques".
3.8.Conclusion
KZNGOV Hospital is an old and established institution that was also one of the main
vehicles for teaching the under-privileged non-white medical students during the
apartheid days. Despite its limitations when it came to financial resources and the latest
modem medical technology, it grew to be recognised world-wide as a top training and
teaching institution that produced medical graduates of high calibre in conjunction with
the attached medical school. Just prior to the opening of the Inkosi Albert Luthuli
Hospital, KZNGOV was the main tertiary hospital in Kwazulu Natal, with modem
technology that was comparable to other first-world hospitals.
The senior medical staff - including the nurses and doctors - are well qualified and their
services are excellent. This statement can be borne out by the so-called "poaching" of
our medical staff by other first-world countries like the United Kingdom and Australia.
The practice of medicine and surgery cannot be faulted at KZNGOV Hospital, although
the unfortunate epidemic of HIV / AIDS and tuberculosis is placing extreme pressure on
the human and financial resources at the hospital. The hospital administration and the
heads of the various departments have to evaluate costs carefully, and still provide a
quality health service to the patients.
The department of general surgery and the theatre staff have succeeded in providing
quality surgical care to the hospital's patients. Their sterilisation and disinfection
procedures are excellent, and there have been very few adverse effects on patients
undergoing surgery. The surgical procedures themselves are done by experienced
surgeons, and are performed according to international standards. Patient care is not
compromised. The instruments used in theatre are well cared for, and in good working
order. The operating theatre staff ensure that defective instruments are not used, as this
will affect the standard oftreatment given to the patients.
CHAPTER 4: RESULTS AND ANALYSIS OF THE RESULTS
4.1. Introduction
This chapter presents, discusses and attempts to analyse the results of the study. The
three areas to be analysed are:
• The profiles of the fifty patients that underwent a laparoscopic cholecystectomy
during the period 1/1/2002 to 31/1/2003.
• Discussion and analysis of the interviews with the consultant surgeons.
• A comparison of the costs of the different instruments - both re-usable and
disposable- and their marginal contribution to the cost of the laparoscopic
cholecystectomy as a whole.
4.2. The Patients
A convenience sample of fifty patients was chosen for this study. All these patients are
hospital patients who had had a laparoscopic cholecystectomy at KZNGOV Hospital
during the period 1/1/2002 to 31/1/2003. Re-usable instrumentation was used for all
these procedures.
The profiles that were considered were:
• Gender
• Age
• Length ofhospital stay in days
• Duration ofoperation in minutes
• Intra-operative complications: Organ injury and bleeding
• Post-operative complications: Immediate bleeding, infection at 2 weeks post-op, and
infection at 6 weeks post-op.
• Difficulty with surgical technique.
4.2.1. Gender of the Patients
In the sample of fifty patients, 5 were male and 45 were female. The male patients
comprised 10% of the sample. Of the original 95 patients who had had laparoscopic
cholecystectomies from 11112002 to 31/112003, and complete notes could not be obtained
for them all, 14 were male. In percentage terms tbis is 14.7%. This finding is consistent
with the fact that gall-bladder disease is more common in females.
4.2.2. Age
Table 4.1: Analysis ofthe ages ofthe fifty patients.
Average age 47 years
Median age 41 years
Mode (most frequently appearing age) 41 years
Minimum age (Youngest patient) 16 years
Maximum age (Oldest patient) 78 years
Table 4.2: The numbers of patients in different age groups.








The following graph (Figure 4.1) shows the relationship between the different age ranges
and the number ofpatients that have had laparoscopic cholecystectomies.
Figure 4.1: Relationship between Age and Gall-bladder Disease











10,19 20,29 30,39 40,49 50,59
Age Range
60,69 70,79
It can be seen that the majority of the patients fall between the ages of 40 years and 59
years. This is also in keeping with the age incidence of gall-bladder disease in the
general population.
4.2.3. Length of Hospital Stay in Days
Table 4.3: Length of Hospital Stay
Average length of stay 4 days
Median length of stay 3 days
Maximum (longest stay) 18 days
Minimum (shortest stay) 2 days
Mode (most frequently occurring length of stay) 2 days
The mode is the most important indicator in this set of values, as it shows the most
frequently occurring value in this range. A hospital stay of 2 days after a laparoscopic
cholecystectomy is in keeping with first world standards. The outlier, Le. the patient
who stayed in hospital for 18 days, had no post-operative complications. She had a
social problem and had to wait for relatives to fetch her from the hospital as she had no
means to go home.
4.2.4. Duration of Operation in Minutes





Maximum (longest operating time) 120 minutes
Minimum (shortest operating time) 15 minutes
The Society of American Gastrointestinal Endoscopy surgery did a study in 1996 on the
time taken to perform a laparoscopic cholecystectomy. Their preliminary results suggest
that operative time averages 76 minutes, but the range is from 40 minutes to 89 minutes.
Only four of the operations in this study took longer than 89 minutes. Thus these are
acceptable values for the duration of laparoscopic cholecystectomies in general.
4.2.5. Intra-operative Complications
None of the fifty patients in the sample had any intra-operative complications. There
was no bleeding nor any organ injury.
4.2.6. Post-operative Complications.
None of the fifty patients in the study developed any post-operative complications.
None had any immediate post-operative bleeding, or developed infection later. All these
patients attended the surgical follow-up clinics, first at two weeks post-operatively and
again at six weeks post-operatively. There was no intra-abdominal infections or wound
sepsis.
4.2.7. Difficulty with Surgical Technique
No problems arose during any of the fifty laparoscopic cholecystectomies in this study.
The surgeons had no difficulty with their surgical techniques before or during the
operation.
4.3. Interviews with the Surgeons: Results and Analysis
Only three of the consultant surgeons agreed to participate in the interview. The rest
were not available, inaccessible or had emigrated.
4.3.1. Number of Years as a Practising Surgeon
Two ofthe three surgeons interviewed were practising for more than 16 years. The third
surgeon was in practice for between 12 to 16 years. Thus all three are experienced in
their field.
4.3.2. Type Of Practice
Ofthe three surgeons interviewed:
• One is mainly in private practice, but works as a part-time consultant at various
government hospitals.
• One surgeon works full-time in a government hospital, but also does some part-time
private work.
• The third surgeon is a surgical consultant and in hospital practice only.
4.3.3. Number of Laparoscopic Cholecystectomies done per month by each
Surgeon
All three surgeons perform more than 16 laparoscopic cholecystectomies per month.
They have extensive experience with the procedure and the instrumentation.
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4.3.4. Use of Instruments
All three surgeons have used both re-usable and disposable laparoscopic instruments
during their surgical careers. They are completely familiar with both types ofdevices.
4.3.5. Cost-effectiveness of Disposable Instruments
All three of the interviewees thought that disposable instrumentation was not cost-
effective. A surprising aspect of this answer is that even the surgeon who is in private
practice preferred to use the re-usable devices. He preferred these instruments despite
the higher remuneration obtained in private hospitals when disposable instruments are
used.
4.3.6. Quality of Instruments
All three surgeons agreed that the disposable instruments were not in any way superior to
the re-usable counterparts. They did not regard the safety shield that comes with the
disposable trocars to be an advantage. All three said that the shield did not really prevent
all intra-abdominal injuries. Surgical technique and careful use ofthe trocars were more
relevant to the prevention of injuries.
4.3.7. Preference of Type of Instruments
All three interviewees preferred the re-usable instruments. One reason was the relative
simplicity of the design. The other important reason cited was the large cost saving
obtained by using the re-usable devices.
4.3.8. Difficulty Encountered During Operations
None ofthe surgeons found the re-usable instrument more difficult to use as compared to
the disposable device.
4.3.9. Hampering of Operative Technique
All of the three surgeons agreed that the re-usable devices did not cause difficulty with
their surgical techniques. They are au fait with the use of both the disposable and re-
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usable instruments, and often found the re-usable instrumentation more practical and
easier to handle.
4.3.10. Adverse Patient Outcomes
No patient of any of the three interviewees suffered as a result of re-usable
instrumentation being used on them. They did not encounter any bowel or other organ
injuries, increased rates of infection, uncontrollable bleeding nor increased rates of
wound sepsis.
4.4.Costs of the Instruments
This study is focusing on the use ofonly the three following instruments:
• Trocars (with cannulae/sleeves): 11.Omm and 6.0mm diameters
• Endoshears / scissors
• Clip Applicators and clips.
4.4.1. Costs of the Disposable Instruments
Quotes for the above instrwnents were obtained from three disposable device suppliers.
The names of the companies will not be disclosed as they were promised confidentiality.
The following table (Table 4.5) shows the prices of the disposable instrwnents, and an
average price was calculated for the purposes of this study. This was done to simplify
the costs involved.
Table 4.5: Comparison of the Costs of Disposable Instruments.
Instrument Company A CompanyB CompanyC Average Price
Price (Rands) Price (Rands) Price (Rands) (Rands)
Trocar 11.0mm 1 134-75 908-34 1295-00 1 112-70
Sleeve 11.0mm 401-33 368-34 370-00 379-89
Trocar 6.0mm 1 121-13 908-34 1069-00 1 032-82
Sleeve 6.0mm 337-96 368-34 297-00 328-43
Multiple Clip 2229-54 1 900-00 2200-00 2 109-85
Applier
Endoshears 1 360-44 1462-00 1 300 1 374-15
4.4.2. Costs of Re-usable Instruments
The following table gives the list of the re-usable instruments and their respective prices.
I have specifically chosen the instruments that are used at KZNGOV Hospital. Each re-
usable device is assumed to be used for 250 laparoscopic procedures. This is a
conservative estimate that will be used for the purposes ofthis study.
Table 4.6: Costs of the Various Re-usable Instruments.
Instrument Price (Rands) Number of times Price per
Used Operation
Trocar 11.0mm 2692-98 250 10-77
Sleeve 11.0mm 508-77 250 2-03
Trocar 6,Omm 2434-21 250 9-74
Sleeve 6.0mm 671-05 250 2-68
Scissors - Reusable 2240-00 250 8-96
handle
Scissors - 857-28 5 171-46
Disposable tip
Clip Applicator 9117-38 250 36-47
Clips-8 per cartridge 501-60 1 501-60
Cleaning Brush for 55-20 200 0-26
Sheath ofTrocar
Cleaning Brush for 91-50 200 0-46
Jaws of Scissors
4.5. Marginal Cost for One Procedure using Disposable and Re-usable Instruments
For the purpose of this study, only the cost of the above three instruments will be
considered. The cost calculated will be the costs of these instruments only, all other
instruments in the laparoscopic pack will be considered as standard. The average cost
ofthe disposable instruments will be used. The calculation will be done assuming the 3-
port technique for the laparoscopic cholecystectomy will be performed.
The costs of the brushes used to clean the re-usable instruments after surgery are
negligible, but will be included in the calculation of marginal costs. The re-usable
instruments are sterilised and disinfected with all the other surgical packs used in
KZNGOV theatre, so this cost will not be included in the calculation.
The cartridge ofeight titanium clips is offered to the government at a special tender price.
This price will not be used in the calculation ofthe costs ofthe procedure. The price that
is paid in the private sector will be used. This is done so that a fair estimate of the
marginal costs of the laparoscopic procedures using either disposable or re-usable
instrumentation can be calculated.
All other costs pertaining to the procedure of the laparoscopic cholecystectomy will not
be taken into account, e.g. theatre costs, anaesthetic drugs and instruments, surgeon's
fees. These have to be omitted as they vary in the private and public hospital sectors.
Government hospital doctors earn a fixed monthly salary regardless of the number of
operations they do, whereas, itemised billing is most often used in private practice.
Table 4.7: Marginal Cost of One Laparoscopic Cholecystectomy using Disposable
Devices
Instrument Number used Cost (Rands)
Trocar 1l,Omm 2 2225-40
Sleeves 11.0mm 2 759-78
Trocar 6.0mm 1 1 032-82
Sleeve 6.0mm 1 328-43
Multiple Clip Applier I 2 109-85
Endoshears / Scissors 1 1 374-15
TOTAL COST 7830-43
Table 4.8: Marginal Cost of One Laparoscopic Cholecystectomy Using Re-usable
Devices
Instrument Number Used Cost (Rands) per
Procedure
Trocar 11.0mm 2 21-54
Sleeve 11.0mm 2 4-06
Trocar 6.0mm 1 9-74
Sleeve 6.0mm I 2-68
Scissors Handle 1 8-96
Scissors Tip 1 171-46
Clip Applicator 1 36-47
Clips - 8 per cartridge 1 501-60
Cost ofCleaning Brushes 0-72
TOTAL COST 757-23
4.6. Conclusion
Three different areas pertaining to the laparoscopic cholecystectomy were analysed in
this study:
• The patients that underwent the procedure between the periods 1/1/2002 to 31.1.2003
and their intra- and post-operatives outcomes.
• The input from the surgeons performing the procedure.
• The costs of the three common instruments used in the laparoscopic cholecystectomy
- trocars, clip applicators and scissors.
4.6.1. The Patients' Profiles
A sample of fifty patients who underwent a laparoscopic cholecystectomy during the
period 1/1/2002 to 31/1/2003 was chosen. Although this was a convenience sample, the
patient profiles such as age and gender, fit in with the incidence of gallbladder disease in
the general population, Le. it is more common in females over the age of forty years.
This sample could to some degree be called representative. The average length of
hospital stay was four days, although 36% of the patients in the study had a hospital stay
of two days and 22% of the patients stayed three days. This comprises 58% of the
patients in the sample. The average operating time was 58 minutes which correlates well
to the average time of 76 minutes in the previously mentioned American study. None of
the surgeons had any problems with surgical technique using the re-usable instruments,
and none of the patients in the sample developed any complications during or after the
operation.
4.6.2. The Interviews with the Surgeons
The unfortunate aspect of the study was that only three surgeons were willing to be
interviewed. These three surgeons, however, were well experienced in their fields, and
two of them were practising general surgery for more than twenty years. All three
surgeons had extensive experience with the procedure of the laparoscopic
cholecystectomy. They all agreed that the re-usable instrumentation posed no threat to
the patients, were easy to use and were far more cost-effective. All three surgeons
actually preferred to use the re-usable instruments.
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4.6.3. Costs of the Instruments
The three instruments that this study concentrated on are the trocars (ll.Omm and
5.0mm), the clip applicator and the endoshears / scissors. These instruments were
chosen because they are common to all laparoscopic cholecystectomies and are also
expensive items in the laparoscopic surgical pack. The results show that the extra costs
incurred by using the disposable equivalents of the above instruments in the procedure is
approximately R7 000 - 00. This figure is the same as that obtained from one of the
major health insurance companies in South Africa. It was not possible to obtain statistics
about the number of laparoscopic cholecystectomies done in private hospitals, but a
substantial number are being performed. Assuming a conservative estimate of a
thousand ofthese operations being done in Kwazulu Natal per month in private hospitals,
the use of these three particular disposable instruments adds a massive R7.073 million to
the medical costs of the operation. This amount is borne by the medical aid companies
and the patients.
CHAPTER 5: CONCLUSIONS AND RECOMMENDATIONS
5.1. Introduction
The evaluation ofthe use of re-usable instrumentation in laparoscopic surgery is only one
of the many areas in the health industry where costs and outcomes can be evaluated.
Costs in other areas of medicine can be re-evaluated and appropriate changes made.
This is especially important in our present economic environment where medical costs
are spiralling out of controL This conclusion was drawn from the literature review as
well as from the case study.
5.2. Quality in lIealth Care
During these times of economic retraction, substantial interest had focused on the cost of
health care. Because surgeons perform costly procedures, the health care system has
focused on them, and particularly on laparoscopy (Traverso, 1996). Technology has
allowed surgeons to spend more money, whereas, the business ofhealth care concentrates
on making a profit for its investors. The business of medicine should not be distracted,
however, by costs when its priority is to provide quality health care to the patient
population. Surgeons and other health care workers should fIrst be interested in the
quality of health care, and then dwell on a reasonable cost for the health care product.
Industry has allowed surgeons to utilise advanced technology. The responsibility of the
surgeons who use this technology is to avoid the gimmick and provide the quality at a
reasonable cost (Traverso, 1996).
5.3. Definitions of Costs
The business method of evaluating costs begins by categorising costs into controllable
(direct) versus uncontrollable (indirect) costs. This method allows for strategic analysis
and planning (Traverso, 1996).
5.3.1. Direct versus Indirect Costs
A hospital provides hundreds of laparoscopic procedures. The inherent overhead costs
of the hospital are not controllable e.g. mortgage payments, rent, electricity and salaries.
These do not change regardless ofhow many procedures are performed. These costs are
not directly related to patient care and are therefore termed indirect costs. The remaining
costs are termed direct because they arise directly from patient care e.g. nurses salaries
and disposable equipment. These direct costs are controllable because the administration
can choose how each patient's operation can be carried out most efficiently.
Variable costs are another category of costs - these costs increase with the number of
procedures that are performed. The costs that fall within the direct variable category are
those that can be most influenced by the surgeons e.g. the cost of the disposable
instrumentation and the controversy that arises from this. Modifying a laparoscopic
procedure with innovative ideas to decrease the need for costly equipment is a credible
goal for pioneers of laparoscopy (Traverso,1996).
5.4.The Surgical Value Package
We know that quality of health care comes ftrst, and then attention is directed towards
costs. Value assessment is the knowledge of the strengths and weaknesses of both cost
analysis and outcome. The key to evaluating a procedure is to determine its value
(Traverso, 1996). The value is determined by assessing a procedure's utilisation,
outcomes and costs. Utilisation involves early treatment and avoids neglected disease.
Thus the approriateness ofthe utilisation can be determined only by an outcome study.
An outcome study is synonymous with quality assessment. Outcomes deal with
morbidity, mortality, and the short- and long-term effects ofthe procedure. The outcome
study of the ftfty patients that were selected for this work shows that the patients had
suffered no adverse effects from the surgical techniques or from the use of re-usable
laparoscopic instrumentation. Overall; an increase in quality in a global perspective
decreases the costs of the procedure to the health care community. When the quality of
patient management can be maintained, then a decrease in global costs increases value.
The concept of increasing value by increasing quality without an attempt to decrease
costs is a very important principle that the health care system must learn in our ever-
challenging medical environment (Traverso, 1996).
5.5. Recommendations
This case study how the medical profession can influence the costs ofhealth care -and in
many cases - considerably. The Department of Surgery at KZNGOV Hospital in
conjunction with the theatre committee have managed the very delicate balancing act of
combining a quality health service (in terms of the operations performed) with financial
resources that are stretched to a maximum. Their criteria for the choice of patients for
laparoscopic cholecystectomies is a good benchmark for any other surgeon in practice.
Laparoscopic procedures are not done unnecessarily as is the case in the United States
and other developed countries. In these countries doctors are relaxing their selection and
referral criteria, and more patients are undergoing laparoscopic cholecystectomies.
Because the private and public sectors cannot be considered as two completely separate
entities, surgeons in private practice should take greater cognisance of the costs involved
in every operation they perform. Medical aid schemes and patients who pay for health
care out of their own pockets are finding it more and more difficult to keep up with ever
increasing health care costs. Eventually the burden reverts to the State when medical aid
funds run out, or patients cannot afford the high medical bills themselves. This
ultimately forces health insurance companies to increase premiums, and it also places a
larger load on the taxpayer. The government itself is also affected because it is also one
of the largest employers in the country. Government heavily subsidises the health
insurance premiums paid by its employees. All these factors eventually form a vicious
never-ending cycle that does not benefit the South African economy as a whole.
Another area that I believe is a very important one to consider is the environment.
Disposable commodities in general must impact negatively on the environment.
Environmental damage is presently at the forefront of world debates. In the United
States many companies developed during the "disposables boom" which reprocess
disposable surgical devices. This has been approved by the American Food and Drug
Administration. But now there is growing concern that many of these devices are not
suitable for re-processing. There is an issue of guaranteed sterility, and of the potential
degradation of products. These reprocessed products may dislodge or malfunction if
repeated sterilisation is performed. Disposable devices are not designed for re-use, are
not easy to clean, and this practice is definitely not recommended by disposable device
manufacturers.
Laparoscopy has been in use for many decades, and there is no known case of infection
transmission by laparoscopic instruments. Surgeons must continually re-examine their
own practices and see how they could achieve the balance between cost-effectiveness and
patient protection.
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I am a final year student at the Graduate School ofBusiness, University ofNatal, Durban.
I am currently working on my dissertation towards an MBA degree in Strategic Financial
Management. The title of my thesis is: "An Investigation into the Cost-effectiveness of
using Re-usable Instrumentation in Laparoscopic Colecystectomy". My objective is to
expand the body ofknowledge about this important area oflaparoscopic surgery.
To accomplish this, I need to approach qualified and experienced surgeons like you who
have had much experience in this field of surgery. Your help with the questions on the
attached pages will make a real contribution to the accuracy and success of this study.
Your input will be treated with strict confidence and will be available only to me and my
supervisor. Any publication will only be ofstatistical totals, and will not include names.
Your assistance will be greatly appreciated and will help me to know more about the
instrumentation used in laparoscopic cholecystectomies. It may also ultimately be of
benefit to the patients who will undergo these procedures.
Yours Sincerely
Dr. S. R Maharaj.
1
OUESTIONS
1. How long have you been practising as a surgeon?
a. 1-4years
b. 4-8ye¥s
c. 8 - 12 years
d. 12 - 16 years
e. More than 16 years.
2. Are you in :
a. Hospital practice only?
b. Private practice only?
c. Both hospital and private practice?





e. More than 16.













7. Which of the two types of instruments - disposable or re-usable - do you prefer to
use? Why?
Feasibility of Use








10. Have you had any of the following adverse patient outcomes by using re-usable
instruments during laparoscopic cholecystectomies?
a. Bowel/Other organ injury
• Yes
• No
b. Increased rate of intra-abdominal infection
• Yes
• No
c. Increased rate ofwound sepsis
• Yes
• No
d. Immediate bleeding post-operatively
• Yes
• No
e. Delayed bleeding post operatively
• Yes
• No
THANK YOU
